Skip to content

Clinical effectiveness of remote management in patients with diabetic macular edema receiving long-term intravitreal anti-VEGF therapywith Diabetes Macular Edem

Clinical effectiveness of remote management in patients with diabetic macular edema receiving long-term intravitreal anti-VEGF therapywith Diabetes Macular Edem

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090348
Enrollment
Unknown
Registered
2024-09-27
Start date
2023-09-12
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Macular Edema

Interventions

Case series:none

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Men or women aged between 18 and 75; (2) One or both eyes were diagnosed as diabetes macular edema; (3) No serious systemic complications; (4) New initiation of intravitreal injection of anti VEGF drugs for the treatment of the eye; (5) Treatment eye retinal fovea thickness (CRT) = 300 µm;(6) The therapeutic eye ETDRS method tests BCVA at 39-73 letters (Snellen's visual acuity is approximately 20/40 to 20/160) at 4 meters; (7) The research subjects or caregivers are proficient in using smartphones and WeChat

Exclusion criteria

Exclusion criteria: (1) Individuals who have previously undergone surgery, laser therapy, or intravitreal hormone therapy for fundus diseases; (2) Confirmed patients with Alzheimer's disease, intellectual disability, or mental illness; (3) Pregnant women; (4) Patients who cannot be followed up locally.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuity, BCVA;

Secondary

MeasureTime frame
Central Retinal Thickness;number of intravitreal injection;number of follow-up;number of lost follow-up;incidence of adverse events;

Countries

China

Contacts

Public ContactXu xun

Shanghai General Hospital

drxuxun@sjtu.edu.cn+86 133 8625 9538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026